Krishnansu S. Tewari, MD of University of California, Irvine discusses the impact of the FOCUS trial on clinical practice, explaining…
Browsing: Acute Lymphoblastic Leukemia
Mark Rutstein, Vice President of Oncology Development of Bayer discusses the xofigo injection, a treatment method for patients with castration-resistant…
Mark Rutstein, Vice President of Oncology Development of Bayer gives an overview of three abstracts that discussed the use of…
Mark Rutstein, Vice President of Oncology Development of Bayer discusses his take on the treatment trends for 2017 and 2018,…
Mark Rutstein, Vice President of Oncology Development of Bayer discusses the RIFTOS trial, which focused on the use of sorafenib…
Mark Rutstein, Vice President of Oncology Development of Bayer gives an overview of two poster presentations that focus on the…
Mark Rutstein, Vice President of Oncology Development of Bayer discusses Bayers current and approved products and new and diverse advances…
Mark Rutstein, Vice President of Oncology Development of Bayer gives an overview of the ARASENS study, which is a phase…
Howard S. Hochster, MD of Yale School of Medicine gives an overview of his presentation, The Impact of Molecular Subsets…
Howard S. Hochster, MD of Yale School of Medicine discusses the importance of recommending molecular testing early on to patients…
Howard S. Hochster, MD of Yale School of Medicine discusses the impact of molecular testing and screening on potential clinical…
Christopher Crane, MD of Memorial Sloan-Kettering gives an overview of his presentation, What is the Optimal Neoadjuvant Strategy in Pancreatic…
Christopher Crane, MD of Memorial Sloan-Kettering gives an overview of his presentation, Does Radiation Therapy Play a Role in Gastric…
Mark A. Schattner, MD of Memorial Sloan-Kettering gives an overview of his presentation, Novel Endoscopic Management of Pancreaticobiliary Cancers, which…
Mark A. Schattner, MD of Memorial Sloan-Kettering explains whether or not there is screen for pancreatic cancer. This was recorded…
David Ilson, MD, PhD of Memorial Sloan-Kettering discusses questions from the audience that focused on the appropriate chemotherapy for gastric…
David Ilson, MD, PhD of Memorial Sloan-Kettering explains the impact of radiation therapy on clinical practice. He argues that adding…
David Ilson, MD, PhD of Memorial Sloan-Kettering gives an overview of his presentation, Debate: Does Radiation Therapy Play a Role…
Ghassan Abou-Alfa, MD of Memorial Sloan-Kettering discusses his presentation, Overview of Novel Treatments for HCC in the Era of Hep…
Ghassan Abou-Alfa, MD of Memorial Sloan-Kettering discusses the impact of regorafenib for hepatocellular carcinoma (HCC) treatment. This was recorded at…
Jonathan R. Strosberg, MD of Moffitt Cancer Center gives an overview of his presentation, Management of Neuroendocrine Tumors, which was…
Jonathan R. Strosberg, MD of Moffitt Cancer Center discusses the impact of circulating tumor DNA on oncology treatment and management.…
Jonathan R. Strosberg, MD of Moffitt Cancer Center gives an overview of his presentation, Is There a Role for Surgical…
Yelena Yuriy Janjigian, MD, Memorial Sloan-Kettering gives an overview of her presentation, Molecular Subtyping/Profiling and Update in HER2 Targeted Therapy,…
Yelena Yuriy Janjigian, MD of Memorial Sloan-Kettering explains whether or not PDL-1 is a sufficient biomarker in gastric disease. She…
Yelena Yuriy Janjigian, MD of Memorial Sloan-Kettering discusses her presentation, Is Surgery Required After Chemoradiotherapy for Squamous Cancer of the…
http://cancertherapeutics.alliedacademies.com/
Cathy Eng, MD, FACP of MD Anderson Cancer Center discusses her second presentation, which focused on management of anal carcinoma.…
Cathy Eng, MD, FACP of MD Anderson Cancer Center gives an overview of her first presentation, Is Circulating Tumor DNA…
Michael Choti, MD, MBA of UT Southwestern Medical Center gives an overview of his presentation, Is There a Role for…
Michael Choti, MD, MBA of UT Southwestern Medical Center discusses questions from the audience on how to manage early stage…
Zsofia K. Stadler, MD of Memorial Sloan-Kettering explains the role of aspirin therapy in patients with colon cancer and other…
Zsofia K. Stadler, MD of Memorial Sloan-Kettering gives an overview of her second presentation, which focused on the role of…
Tanios S. Bekaii-Saab, MD, FACP of Mayo Clinic gives an overview of his second presentation, which focused on optimal adjuvant…
Tanios S. Bekaii-Saab, MD, FACP of Mayo Clinic explains whether or not there is a standard second line treatment for…
Tanios S. Bekaii-Saab, MD, FACP of Mayo Clinic gives an overview of his first presentation, which focused on the availability…
Tanios S. Bekaii-Saab, MD, FACP of Mayo Clinic explains how to integrate HER2, BRAF, and immunotherapy into clinical practice. This…
Eric Van Cutsem, MD, PhD of University of Leuven gives an overview of his presentation which focused on how to…
Eric Van Cutsem, MD, PhD of University of Leuven gives an overview of his second presentation, which focused on the…
Eric Van Cutsem, MD, PhD of University of Leuven discusses the impact of left-sided tumors versus right-sided tumors on research…
Scott Kopetz, MD, PhD, FACP of MD Anderson Cancer Center discusses the use of technology and its potential breakthroughs for…
Scott Kopetz, MD, PhD, FACP of MD Anderson Cancer Center gives an overview of his presentation, which focused on treatment…
Scott Kopetz, MD, PhD, FACP of MD Anderson Cancer Center gives an overview of the novel therapies that are being…
Christopher Leigh Hallemeier, MD of Mayo Clinic gives an overview of Dr. Julio Garcia-Aguilar’s latest research trial, A Phase II…
Christopher Leigh Hallemeier, MD of Mayo Clinic gives an overview of his presentation, Is Observation Without Surgery Reasonable for Rectal…
Christopher Leigh Hallemeier, MD of Mayo Clinic explains whether or not clinicians can use non-operative management for patients with stage…
Julio Garcia-Aguilar, MD, PhD of Memorial Sloan-Kettering gives an overview of new data regarding watch-and-wait approaches in patients with rectal…
Julio Garcia-Aguilar, MD, PhD of Memorial Sloan-Kettering gives an overview of his presentation, Is Observation Without Surgery Reasonable for Rectal…
Julio Garcia-Aguilar, MD, PhD of Memorial Sloan-Kettering discusses patient concerns of risks with delaying surgery months or years after receiving…
http://cancertherapeutics.alliedacademies.com/ Cancer Therapeutics 2017 will be a great platform for research scientists and young researchers to share their current findings…